This biotechnology company has seen a mixed track record when it comes to estimate revisions of one increase and one decrease over the past 30-day time frame, while the Zacks Consensus Estimate hasn’t been in a trend. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Athersys currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Some better-ranked stocks in the same sector include Heska Corporation (HSKA), Actelion Ltd. (ALIOF) and AMAG Pharmaceuticals, Inc. (AMAG). All these stocks hold a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
ATHERSYS INC (ATHX): Free Stock Analysis Report
HESKA CORP (HSKA): Free Stock Analysis Report
ACTELION LTD (ALIOF): Free Stock Analysis Report
AMAG PHARMACEUTICALS INC (AMAG): Free Stock Analysis Report
Zacks Investment Research
- Finance Trading
- Personal Investing Ideas & Strategies